Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 15,935,472
- Share change
- +1,701,786
- Total reported value
- $338,961,585
- Price per share
- $21.49
- Number of holders
- 52
- Value change
- +$30,078,348
- Number of buys
- 36
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
5.8%
|
3,355,466
|
$92,570,000 | — | 30 Jun 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.2%
|
1,869,680
|
$54,539,000 | — | 30 Jun 2019 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
3.2%
|
1,861,623
|
$54,304,000 | — | 30 Jun 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
1,119,963
|
$32,669,000 | — | 30 Jun 2019 | |
| Redmile Group, LLC |
13F
|
Company |
1.8%
|
1,021,808
|
$29,806,000 | — | 30 Jun 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
671,978
|
$19,601,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
1.1%
|
650,000
|
$18,961,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.96%
|
552,730
|
$16,123,000 | — | 30 Jun 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.71%
|
406,471
|
$11,858,000 | — | 30 Jun 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.7%
|
400,000
|
$11,668,000 | — | 30 Jun 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.66%
|
376,900
|
$10,994,000 | — | 30 Jun 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.61%
|
350,944
|
$9,718,000 | — | 30 Jun 2019 | |
| Atom Investors LP |
13F
|
Company |
0.35%
|
199,513
|
$5,820,000 | — | 30 Jun 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.32%
|
182,671
|
$5,329,000 | — | 30 Jun 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.23%
|
130,000
|
$3,792,000 | — | 30 Jun 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.2%
|
115,000
|
$3,355,000 | — | 30 Jun 2019 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
104,883
|
$3,059,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.17%
|
100,000
|
$2,917,000 | — | 30 Jun 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
99,818
|
$2,911,000 | — | 30 Jun 2019 | |
| Casdin Capital, LLC |
13F
|
Company |
0.15%
|
85,000
|
$2,479,450 | — | 30 Jun 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
79,662
|
$2,324,000 | — | 30 Jun 2019 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.13%
|
74,621
|
$2,177,000 | — | 30 Jun 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.09%
|
50,167
|
$1,463,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.08%
|
45,651
|
$1,332,000 | — | 30 Jun 2019 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
0.07%
|
40,000
|
$1,172,000 | — | 30 Jun 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.06%
|
36,355
|
$1,060,000 | — | 30 Jun 2019 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.06%
|
34,000
|
$992,000 | — | 30 Jun 2019 | |
| Laurion Capital Management LP |
13F
|
Company |
0.04%
|
25,000
|
$729,000 | — | 30 Jun 2019 | |
| NORGES BANK |
13F
|
Company |
0.04%
|
25,000
|
$729,000 | — | 30 Jun 2019 | |
| Sculptor Capital LP |
13F
|
Company |
0.04%
|
25,000
|
$729,000 | — | 30 Jun 2019 | |
| Zimmer Partners, LP |
13F
|
Company |
0.04%
|
25,000
|
$729,000 | — | 30 Jun 2019 | |
| DC Investments Management, LLC |
13F
|
Company |
0.04%
|
23,464
|
$684,000 | — | 30 Jun 2019 | |
| Blackstone Inc. |
13F
|
Company |
0.04%
|
20,500
|
$598,000 | — | 30 Jun 2019 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
16,202
|
$473,000 | — | 30 Jun 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
13,400
|
$391,000 | — | 30 Jun 2019 | |
| KCL Capital, L.P. |
13F
|
Company |
0.02%
|
10,000
|
$292,000 | — | 30 Jun 2019 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.01%
|
7,891
|
$230,000 | — | 30 Jun 2019 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.01%
|
7,500
|
$219,000 | — | 30 Jun 2019 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
5,000
|
$146,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,550
|
$104,000 | — | 30 Jun 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.01%
|
3,000
|
$88,000 | — | 30 Jun 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
2,500
|
$73,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,520
|
$44,000 | — | 30 Jun 2019 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0%
|
1,000
|
$29,000 | — | 30 Jun 2019 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0%
|
1,000
|
$29,000 | — | 30 Jun 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
914
|
$27,000 | — | 30 Jun 2019 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
240
|
$7,000 | — | 30 Jun 2019 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q3 2019
As of 30 Sep 2019,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,935,472 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, GILDER GAGNON HOWE & CO LLC, Cormorant Asset Management, LP, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, and BlackRock Inc..
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
47
Q3 2019 holders
52
Holder diff
5
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.